David J. Erle

David J. Erle

orcid

Research Focus & Metrics

Academic Career Length

36Years (1991-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2014 in Cancer Cell
Verified
Journal Article
Closed access
MBMiranda L. Broz
Miranda L. Broz
MBMikhail Binnewies
Mikhail Binnewies
BBBijan Boldajipour
Bijan Boldajipour
ANAmanda E. Nelson
Amanda E. Nelson
JPJoshua L. Pollack
Joshua L. Pollack
MKMatthew F. Krummel
Matthew F. Krummel

7 June 2010 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
APApril E. Price
April E. Price
HLHong-Erh Liang
Hong-Erh Liang
BSBrandon M. Sullivan
Brandon M. Sullivan
RRR. Lee Reinhardt
R. Lee Reinhardt
CEChris J. Eisley
Chris J. Eisley
RLRichard M. Locksley
Richard M. Locksley
Type 2 immunity is a stereotyped host response to allergens and parasitic helminths that is sustained in large part by the cytokines IL-4 and IL-13. Recent advances have called attention to the contributions by innate cells in initiating adaptive immunity, including a novel lineage-negative population of cells that secretes IL-13 and IL-5 in response to the epithelial cytokines IL-25 and IL-33. Here, we use IL-4 and IL-13 reporter mice to track lineage-negative innate cells that arise during type 2 immunity or in response to IL-25 and IL-33 in vivo. Unexpectedly, lineage-negative IL-25 (and IL-33) responsive cells are widely distributed in tissues of the mouse and are particularly prevalent in mesenteric lymph nodes, spleen, and liver. These cells expand robustly in response to exogenous IL-25 or IL-33 and after infection with the helminth Nippostrongylus brasiliensis , and they are the major innate IL-13–expressing cells under these conditions. Activation of these cells using IL-25 is sufficient for worm clearance, even in the absence of adaptive immunity. Widely dispersed innate type 2 helper cells, which we designate Ih2 cells, play an integral role in type 2 immune responses.

1 July 2002 in Nature Medicine
Verified
Journal Article
Closed access
PDF file
DKDouglas A. Kuperman
Douglas A. Kuperman
XHXiaozhu Huang
Xiaozhu Huang
LKLaura L. Koth
Laura L. Koth
GCGrace H. Chang
Grace H. Chang
GDGregory M. Dolganov
Gregory M. Dolganov
DEDavid J. Erle
David J. Erle

2 October 2007 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PWPrescott G. Woodruff
Prescott G. Woodruff
HBHomer A. Boushey
Homer A. Boushey
GDGregory M. Dolganov
Gregory M. Dolganov
CBChris S. Barker
Chris S. Barker
YYYee Hwa Yang
Yee Hwa Yang
JFJohn V. Fahy
John V. Fahy
Airway inflammation and epithelial remodeling are two key features of asthma. IL-13 and other cytokines produced during T helper type 2 cell-driven allergic inflammation contribute to airway epithelial goblet cell metaplasia and may alter epithelial–mesenchymal signaling, leading to increased subepithelial fibrosis or hyperplasia of smooth muscle. The beneficial effects of corticosteroids in asthma could relate to their ability to directly or indirectly decrease epithelial cell activation by inflammatory cells and cytokines. To identify markers of epithelial cell dysfunction and the effects of corticosteroids on epithelial cells in asthma, we studied airway epithelial cells collected from asthmatic subjects enrolled in a randomized controlled trial of inhaled corticosteroids, from healthy subjects and from smokers (disease control). By using gene expression microarrays, we found that chloride channel, calcium-activated, family member 1 ( CLCA1 ), periostin , and serine peptidase inhibitor, clade B (ovalbumin), member 2 ( serpinB2 ) were up-regulated in asthma but not in smokers. Corticosteroid treatment down-regulated expression of these three genes and markedly up-regulated expression of FK506-binding protein 51 ( FKBP51 ). Whereas high baseline expression of CLCA1 , periostin , and serpinB2 was associated with a good clinical response to corticosteroids, high expression of FKBP51 was associated with a poor response. By using airway epithelial cells in culture, we found that IL-13 increased expression of CLCA1 , periostin , and serpinB2 , an effect that was suppressed by corticosteroids. Corticosteroids also induced expression of FKBP51. Taken together, our findings show that airway epithelial cells in asthma have a distinct activation profile and identify direct and cell-autonomous effects of corticosteroid treatment on airway epithelial cells that relate to treatment responses and can now be the focus of specific mechanistic studies.

1 January 1996 in Journal of Experimental Medicine
Verified
Journal Article
Open access
DCD B Corry
D B Corry
HFH G Folkesson
H G Folkesson
MWM L Warnock
M L Warnock
DEDavid J. Erle
David J. Erle
MMM A Matthay
M A Matthay
RLR M Locksley
R M Locksley
Reversible airway hyperreactivity underlies the pathophysiology of asthma, yet the precise mediators of the response remain unclear. Human studies have correlated aberrant activation of T helper (Th) 2-like effector systems in the airways with disease. A murine model of airway hyperreactivity in response to acetylcholine was established using mice immunized with ovalbumin and challenged with aerosolized antigen. No airway hyperractivity occurred in severe combined immunodeficient mice. Identically immunized BALB/c mice developed an influx of cells, with a predominance of eosinophils and CD4+ T cells, into the lungs and bronchoalveolar lavage fluid at the time that substantial changes in airway pressure and resistance were quantitated. Challenged animals developed marked increases in Th2 cytokine production, eosinophil influx, and serum immunoglobulin E levels. Neutralization of interleukin (IL) 4 using monoclonal antibodies administered during the period of systemic immunization abrogated airway hyperractivity but had little effect on the influx of eosinophils. Administration of anti-IL-4 only during the period of the aerosol challenge did not affect the subsequent response to acetylcholine. Finally, administration of anti-IL-5 antibodies at levels that suppressed eosinophils to < 1% of recruited cells had no effect on the subsequent airway responses. BALB/c mice had significantly greater airway responses than C57BL/6 mice, consistent with enhanced IL-4 responses to antigen in BALB/c mice. Taken together, these data implicate IL-4 generated during the period of lymphocyte priming with antigen in establishing the cascade of responses required to generate airway hyperractivity to inhaled antigen. No role for IL-5 or eosinophils could be demonstrated.

10 September 2018 in Nature Immunology
Verified
Journal Article
Closed access
PDF file
RRRoberto R. Ricardo-Gonzalez
Roberto R. Ricardo-Gonzalez
SDSteven J. Van Dyken
Steven J. Van Dyken
CSChristoph Schneider
Christoph Schneider
JLJinwoo Lee
Jinwoo Lee
JNJesse C. Nussbaum
Jesse C. Nussbaum
RLRichard M. Locksley
Richard M. Locksley